C6 Ceramide-d7 (d18:1-d7/6:0)
(Synonyms: N-Caproyl-C18-Sphingosine-d7, Cer-d7(d18:1-d7/6:0), C6 Ceramide-d7, Ceramide-d7 (d18:1-d7/6:0), N-hexanoyl-D-erythro-Sphingosine-d7) 目录号 : GC47014A neuropeptide with diverse biological activities
Cas No.:2692624-22-7
Sample solution is provided at 25 µL, 10mM.
C6 Ceramide-d7 is intended for use as an internal standard for the quantification of short-chain ceramides, such as C2 ceramide , C6 ceramide , and C8 ceramide , by GC- or LC-MS. C6 Ceramide is a cell-permeable analog of naturally occurring ceramides. With a longer carbon chain than C2 ceramide, it is somewhat more hydrophobic, and may more closely mimic the effects of natural ceramides.1 C6 Ceramide mediates many diverse biological activities including apoptosis, activation of protein phosphatase 2A, and inhibition of the mitochondrial respiratory chain.1,2,3,4 It also enhances the expression of COX-2 in rat granulosa cells and stimulates the growth of bovine aortic smooth muscle cells.5,6 C6 Ceramide acts in neuronal axons to inhibit neurite growth.7
1.Dobrowsky, R.T., and Hannun, Y.A.Ceramide stimulates a cytosolic protein phosphataseJ. Biol. Chem.267(8)5048-5051(1992) 2.Cai, Z., Bettaieb, A., El Mahdani, N., et al.Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicityJ. Biol. Chem.272(11)6918-6926(1997) 3.Dobrowsky, R.T., Kamibayashi, C., Mumby, M.C., et al.Ceramide activates heterotrimeric protein phosphatase 2AJ. Biol. Chem.268(21)15523-15530(1993) 4.Gudz, T.I., Tserng, K.Y., and Hoppel, C.L.Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramideJ. Biol. Chem.272(39)24154-24158(1997) 5.Santana, P., Llanes, L., Hernandez, I., et al.Interleukin-1β stimulates sphingomyelin hydrolysis in cultured granulosa cells: Evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesisEndocrinology137(6)2480-2489(1996) 6.AugÉ, N., Andrieu, N., NÈgre-Salvayre, A., et al.The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferationJ. Biol. Chem.271(32)19251-19255(1996) 7.Posse de Chaves, E.I., BussiÈre, M., Vance, D.E., et al.Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neuronsJ. Biol. Chem.272(4)2038-3035(1997)
Cas No. | 2692624-22-7 | SDF | |
别名 | N-Caproyl-C18-Sphingosine-d7, Cer-d7(d18:1-d7/6:0), C6 Ceramide-d7, Ceramide-d7 (d18:1-d7/6:0), N-hexanoyl-D-erythro-Sphingosine-d7 | ||
Canonical SMILES | OC[C@H](NC(CCCCC)=O)[C@H](O)/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H] | ||
分子式 | C24H40D7NO3 | 分子量 | 404.7 |
溶解度 | DMF: >22 mg/ml,DMSO: >20 mg/ml,Ethanol: >33 mg/ml,Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml,PBS (pH 7.2): <50 μg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.471 mL | 12.3548 mL | 24.7097 mL |
5 mM | 0.4942 mL | 2.471 mL | 4.9419 mL |
10 mM | 0.2471 mL | 1.2355 mL | 2.471 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet